Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology shows promise for better drug delivery and cancer treatment.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Melatonin directly affects mouse hair follicles and may influence hair growth.

Some skin conditions are associated with other serious diseases, and office microscopy may miss many fungal infections.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Integrin alphavbeta6 is important for wound healing and hair growth, and blocking it may improve these processes.

Overexpressing ornithine decarboxylase and v-Ha-ras in keratinocytes leads to invasiveness and malignancy.

Ganoderma lucidum can cause severe skin reactions and hair loss.

The new drug carriers show promise for better targeting and treating ovarian cancer.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Radiation damages salivary glands by harming blood vessels, but antioxidants might help protect them.

Keratin proteins are essential for keeping the cells in the human colon healthy and stable.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Overexpression of HDGF in melanocytes does not cause cancer.

Tadalafil and Finasteride may help treat aggressive melanoma.

A rare type of skin cancer on the scalp can be mistaken for hair loss, causing delayed diagnosis and severe damage.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

Blocking specific proteins can help remove aging cells and might treat age-related diseases and promote hair growth.

Syndecan-1 is essential for maintaining skin fat and preventing cold stress.

The transgene likely activated an oncogene or interrupted a tumor suppressor gene, causing melanoma in mice.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.